Table 2. Base-Case Cost-effectiveness Results Compared Among Different Strategies by Initial Screening Age Among 100 000 Cohort Membersa.
Initial screening age, strategy | QALYs | Incremental QALYs | Cost ($, thousand) | Incremental cost ($, thousand) | ICER ($/QALY) | |||
---|---|---|---|---|---|---|---|---|
Vs no screening | Vs the next most effective strategyb | Vs no screening | Vs the next most effective strategyb | Vs no screening | Vs the next most effective strategyb | |||
40-44 y | ||||||||
No screening | 1 659 260 | NA | NA | 25 035 | NA | NA | NA | NA |
Screening once per lifetime | 1 660 347 | 1087 | 1087 | 28 334 | 3299 | 3299 | 3035 | 3035 |
Screening every 10 y | 1 663 677 | 4417 | 3330 | 31 954 | 6919 | 3620 | 1566 | 1087 |
Screening every 5 y | 1 666 345 | 7085 | 2668 | 36 707 | 11 672 | 4753 | 1647 | 1781 |
Screening every 3 y | 1 668 371 | 9111 | 2026 | 42 218 | 17 183 | 5511 | 1886 | 2720 |
Screening every 2 y | 1 669 622 | 10 362 | 1251 | 47 861 | 22 826 | 5643 | 2203 | 4511 |
45-49 y | ||||||||
No screening | 1 572 532 | NA | NA | 26 817 | NA | NA | NA | NA |
Screening once per lifetime | 1 574 161 | 1629 | 1629 | 30 347 | 3530 | 3530 | 2167 | 2167 |
Screening every 10 y | 1 576 941 | 4409 | 2780 | 33 961 | 7144 | 3614 | 1620 | 1300 |
Screening every 5 y | 1 579 145 | 6613 | 2204 | 37 745 | 10 928 | 3784 | 1653 | 1717 |
Screening every 3 y | 1 580 974 | 8442 | 1829 | 42 531 | 15 714 | 4786 | 1861 | 2617 |
Screening every 2 y | 1 582 334 | 9802 | 1360 | 48 190 | 21 373 | 5659 | 2180 | 4161 |
50-54 y | ||||||||
No screening | 1 468 506 | NA | NA | 30 229 | NA | NA | NA | NA |
Screening once per lifetime | 1 470 890 | 2384 | 2384 | 34 142 | 3913 | 3913 | 1641 | 1641 |
Screening every 10 y | 1 472 583 | 4077 | 1693 | 36 373 | 6144 | 2231 | 1507 | 1318 |
Screening every 5 y | 1 474 773 | 6267 | 2190 | 40 356 | 10 127 | 3983 | 1616 | 1819 |
Screening every 3 y | 1 476 325 | 7819 | 1552 | 44 120 | 13 891 | 3764 | 1777 | 2425 |
Screening every 2 y | 1 477 651 | 9145 | 1326 | 49 010 | 18 781 | 4890 | 2054 | 3688 |
55-59 y | ||||||||
No screening | 1 342 830 | NA | NA | 36 095 | NA | NA | NA | NA |
Screening once per lifetime | 1 346 031 | 3201 | 3201 | 40 491 | 4396 | 4396 | 1373 | 1373 |
Screening every 10 y | 1 347 264 | 4434 | 1233 | 42 811 | 6716 | 2320 | 1515 | 1882 |
Screening every 5 y | 1 348 747 | 5917 | 1483 | 45 240 | 9145 | 2429 | 1546 | 1638 |
Screening every 3 y | 1 350 365 | 7535 | 1618 | 49 171 | 13 076 | 3931 | 1735 | 2430 |
Screening every 2 y | 1 351 491 | 8661 | 1126 | 52 843 | 16 748 | 3672 | 1934 | 3261 |
60-64 y | ||||||||
No screening | 1 195 742 | NA | NA | 45 876 | NA | NA | NA | NA |
Screening once per lifetime | 1 199 618 | 3876 | 3876 | 51 081 | 5205 | 5205 | 1343 | 1343 |
Screening every 5 y | 1 201 091 | 5349 | 1473 | 53 970 | 8094 | 2889 | 1513 | 1961 |
Screening every 3 y | 1 202 293 | 6551 | 1202 | 56 498 | 10 622 | 2528 | 1621 | 2103 |
Screening every 2 y | 1 203 210 | 7468 | 917 | 58 779 | 12 903 | 2281 | 1728 | 2487 |
65-69 y | ||||||||
No screening | 1 025 119 | NA | NA | 60 442 | NA | NA | NA | NA |
Screening once per lifetime | 1 029 058 | 3939 | 3939 | 67 233 | 6791 | 6791 | 1724 | 1724 |
Screening every 2 y | 1 030 594 | 5475 | 1536 | 70 810 | 10 368 | 3577 | 1894 | 2329 |
Abbreviations: ICER, incremental cost-effectiveness ratio; NA, not applicable; QALY, quality-adjusted life-year.
QALYs, costs, and ICERs are expressed as the values in 2019.
Compared with the next most effective strategy at the same initial screening age.